Market Research Logo

Global Premature Ejaculation Treatment Market 2017-2021

Global Premature Ejaculation Treatment Market 2017-2021

About Premature Ejaculation Treatment

Premature ejaculation is one of the most common sexual dysfunctions occurring in men. Ejaculation happens sooner than desired, either shortly or before penetration, resulting in distress to either one or both partners involved in sexual intercourse. There is no exact cause that can be associated with the condition though mostly, premature ejaculation can be attributed to personal distress and anxiety. It can affect an individual's relationship with his partner. Premature ejaculation is the most common sexual disorder found in men aged between 18 to 59. Some of the effective treatment options available include psychological counseling, medications, sexual techniques that delay ejaculation, or a combination of these treatments.

Technavio’s analysts forecast the global premature ejaculation treatment market to grow at a CAGR of 8.71% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Premature Ejaculation Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Absorption Pharmaceuticals
  • Bayer
  • Eli Lilly
  • Regent Pacific Group
Other prominent vendors
  • Dong-A Pharmaceutical
  • Emcure
  • Futura Medical
  • GlaxoSmithKline
  • NeuroHealing Pharmaceuticals
  • Pfizer
Market driver
  • High use of off-label drugs
  • For a full, detailed list, view our report
Market challenge
  • Alternative treatments
  • For a full, detailed list, view our report
Market trend
  • Growing online retail sales of drugs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Premature Ejaculation Treatment Market 2017-2021

Technavio recognizes the following companies as the key players in the global premature ejaculation treatment market: Absorption Pharmaceuticals, Bayer, Eli Lilly, and Regent Pacific Group

Other Prominent Vendors in the market are: Dong-A Pharmaceutical, Emcure, Futura Medical, GlaxoSmithKline, NeuroHealing Pharmaceuticals, and Pfizer

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Growing online retail sales of drugs. The advent of the internet has reduced the time involved in the physical buying and selling of products and services for buyers and sellers. In terms of growth of different retail channels through which sexual disorder-related drugs are offered, online retailing will be the fastest channel of distribution during the forecast period. The success of online retailing can be attributed to factors such as the availability of a broad range of products, quick delivery services, and highly competitive prices.”

According to the report, one of the major drivers for this market is High use of off-label drugs. The global premature ejaculation treatment market has witnessed the increased use of off-label drugs belonging to different drug classes such as SSRIs (fluvoxamine, paroxetine, sertraline, and fluoxetine) and PDE5 inhibitors (Cialis, VIAGRA, and Levitra). Pharmacological modification of the ejaculatory response in patients with the condition represents a novel approach for the treatment of premature ejaculation and will lead to the gradual replacement of psychosexual counseling, which was previously regarded as the cornerstone of premature ejaculation treatment.

Further, the report states that one of the major factors hindering the growth of this market is Alternative treatments. While the market has several drugs in the pipeline, the growing number of premature ejaculation cases globally has led to an increase in the number of alternative treatment methods for the disease. Some of the alternate treatment methods include counseling, homeopathy, psychotherapy, yoga, and herbal therapy. There are also other natural treatment options for premature ejaculation such as ginseng tea or supplement, raw almond milk, and Ayurvedic dietary changes that can help in delaying ejaculation.

Companies Mentioned

Absorption Pharmaceuticals, Bayer, Eli Lilly, Regent Pacific Group, Dong-A Pharmaceutical, Emcure, Futura Medical, GlaxoSmithKline, NeuroHealing Pharmaceuticals, and Pfizer

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Global premature ejaculation treatment market: Overview
      • Table Facts about premature ejaculation
  • Premature ejaculation: Disease overview
    • Table Severity levels of premature ejaculation
    • Table Clinical diagnosis of premature ejaculation
    • Table Premature ejaculation classification
  • Market landscape
    • Market overview
      • Table Global premature ejaculation treatment market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline molecules by vendors
    • Table Key clinical trials
  • Market segmentation by route of administration
    • Table Global premature ejaculation treatment market by route of administration 2016
    • Oral route of administration
    • Topical route of administration
  • Market segmentation by drug class
    • SSRIs
      • Table Global premature ejaculation treatment market by SSRIs 2016-2021 ($ millions)
    • PDE5 inhibitors
      • Table Global premature ejaculation treatment market by PDE5 inhibitors 2016-2021 ($ millions)
    • Amide anesthetics
      • Table Global premature ejaculation treatment market by amide anesthetics 2016-2021 ($ millions)
    • Others
      • Table Global premature ejaculation treatment market by others 2016-2021 ($ millions)
  • Regional landscape
    • Table Global premature ejaculation treatment market by region 2016-2021 (% share)
    • Regional comparison
      • Table Regional comparison
    • Premature ejaculation treatment market in Americas
      • Table Premature ejaculation treatment market in Americas 2016-2021 ($ millions)
      • Table Premature ejaculation treatment market in Americas – Year over year growth
    • Premature ejaculation treatment market in EMEA
      • Table Premature ejaculation treatment market in EMEA 2016-2021 ($ millions)
      • Table Premature ejaculation treatment market in EMEA – Year over year growth
    • Premature ejaculation treatment market in APAC
      • Table Premature ejaculation treatment market in APAC 2016-2021 ($ millions)
      • Table Premature ejaculation treatment market in APAC – Year over year growth
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Pharmacologic efficacy of some SSRIs
    • Market challenges
      • Table Premature ejaculation treatment drugs and their subsequent side effects
      • Table Factors challenging the treatment of premature ejaculation
  • Market trends
    • Growing online retail sales of drugs
    • Increase in awareness of premature ejaculation
    • New treatment methods
  • Vendor landscape
    • Competitive scenario
  • Key vendor analysis
    • Absorption Pharmaceuticals
      • Table Absorption Pharmaceuticals: Key highlights
      • Table Absorption Pharmaceuticals: Strength assessment
      • Table Absorption Pharmaceuticals: Strategy assessment
      • Table Absorption Pharmaceuticals: Opportunity assessment
    • Bayer
      • Table Bayer: Key highlights
      • Table Bayer: Strength assessment
      • Table Bayer: Strategy assessment
      • Table Bayer: Opportunity assessment
    • Eli Lilly
      • Table Eli Lilly: Key highlights
      • Table Eli Lilly: Strength assessment
      • Table Eli Lilly: Strategy assessment
      • Table Eli Lilly: Opportunity assessment
    • Regent Pacific Group
      • Table Regent Pacific Group: Key highlights
      • Table Regent Pacific Group: Strength assessment
      • Table Regent Pacific Group: Strategy assessment
      • Table Regent Pacific Group: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report